Soluble biomarkers to predict clinical outcomes in non-small cell lung cancer treated by immune checkpoints inhibitors

Soluble biomarkers to predict clinical outcomes in non-small cell lung cancer treated by immune checkpoints inhibitors

Lung cancer remains the first cause of cancer-related death despite many therapeutic innovations, including immune checkpoint inhibitors (ICI). ICI are now well used in daily practice at late metastatic stages and locally advanced stages after a chemo-radiation. ICI are also emerging in the peri-ope...

Full description

Bibliographic Details
Main Authors:	Julien Ancel, Valérian Dormoy, Béatrice Nawrocki Raby, Véronique Dalstein, Anne Durlach, Maxime Dewolf, Christine Gilles, Myriam Polette, Gaëtan Deslée
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-05-01
Series:	Frontiers in Immunology
Subjects:	liquid biopsy soluble biomarkers immunotherapy non-small cell lung cancer (NSCLC) neutrophil lymphocyte ratio (NLR) circulating tumor (ctDNA)
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1171649/full

Similar Items

Transcriptomic FHITlow/pHER2high signature as a predictive factor of outcome and immunotherapy response in non-small cell lung cancer
by: Audrey Brisebarre, et al.
Published: (2022-12-01)

HER2 Alterations in Non-Small Cell Lung Cancer: Biologico-Clinical Consequences and Interest in Therapeutic Strategies
by: Emma Loeffler, et al.
Published: (2023-12-01)

Programmed Death–Ligand 1 and Vimentin: A Tandem Marker as Prognostic Factor in NSCLC
by: Julien Ancel, et al.
Published: (2019-09-01)

Hypoxia in Lung Cancer Management: A Translational Approach
by: Julien Ancel, et al.
Published: (2021-07-01)

CiliOPD: a ciliopathy-associated COPD endotype
by: Jeanne-Marie Perotin, et al.
Published: (2021-02-01)

Impaired Ciliary Beat Frequency and Ciliogenesis Alteration during Airway Epithelial Cell Differentiation in COPD
by: Julien Ancel, et al.
Published: (2021-08-01)

Sonic hedgehog signalling as a potential endobronchial biomarker in COPD
by: Julien Ancel, et al.
Published: (2020-08-01)

Whole-Exome Sequencing of Bronchial Epithelial Cells Reveals a Genetic Print of Airway Remodelling in COPD
by: Adeline Germain, et al.
Published: (2022-07-01)

Nicotinic Receptor Subunits Atlas in the Adult Human Lung
by: Zania Diabasana, et al.
Published: (2020-10-01)

Assessment of the Association between Entropy in PET/CT and Response to Anti-PD-1/PD-L1 Monotherapy in Stage III or IV NSCLC
by: Julie Malet, et al.
Published: (2023-04-01)

Airway ciliated cells in adult lung homeostasis and COPD
by: Laure M.G. Petit, et al.
Published: (2023-12-01)

Bronchoscopic management of asthma, COPD and emphysema
by: Jeanne Marie Perotin, et al.
Published: (2021-01-01)

Airway epithelial cell differentiation relies on deficient Hedgehog signalling in COPD
by: Randa Belgacemi, et al.
Published: (2020-01-01)

Patient education needs in severe asthma, a pilot study
by: Rodolphe Laurence, et al.
Published: (2024-03-01)

Chr15q25 Genetic Variant rs16969968 Alters Cell Differentiation in Respiratory Epithelia
by: Zania Diabasana, et al.
Published: (2021-06-01)

The prognostic impact of neutrophil to lymphocyte ratio in advanced non-small-cell lung cancer patients treated with EGFR TKI
by: Phan TT, et al.
Published: (2018-11-01)

The Nicotinic Receptor Polymorphism rs16969968 Is Associated with Airway Remodeling and Inflammatory Dysregulation in COPD Patients
by: Lynda Saber Cherif, et al.
Published: (2022-09-01)

Longitudinal Circulating Tumor DNA Analysis in Blood and Saliva for Prediction of Response to Osimertinib and Disease Progression in EGFR-Mutant Lung Adenocarcinoma
by: Chul Kim, et al.
Published: (2021-07-01)

Minimal Residual Disease Monitoring in Radically Treated Non-Small Cell Lung Cancer: Challenges and Future Directions
by: O'Sullivan HM, et al.
Published: (2023-04-01)

EGFR‐plasma mutations in prognosis for non‐small cell lung cancer treated with EGFR TKIs: A meta‐analysis
by: Thang Thanh Phan, et al.
Published: (2022-08-01)

Required Evidence for Clinical Applications of Liquid Biopsy Using Especially CTCs in Lung Cancer
by: Menno Tamminga, et al.
Published: (2020-05-01)

EMT-Associated Heterogeneity in Circulating Tumor Cells: Sticky Friends on the Road to Metastasis
by: Anthony Genna, et al.
Published: (2020-06-01)

Effect of Osimertinib on CTCs and ctDNA in EGFR Mutant Non-Small Cell Lung Cancer Patients: The Prognostic Relevance of Liquid Biopsy
by: Galatea Kallergi, et al.
Published: (2022-03-01)

Cell-Free Tumor DNA (ctDNA) Utility in Detection of Original Sensitizing and Resistant EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC)
by: Jason S. Agulnik, et al.
Published: (2022-02-01)

Monitoring of the presence of EGFR-mutated DNA during EGFR-targeted therapy may assist in the prediction of treatment outcome
by: F.V. Moiseenko, et al.
Published: (2022-01-01)

Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer
by: Veldore VH, et al.
Published: (2018-01-01)

Bronchiectasis in renal transplant patients: a cross-sectional study
by: Pauline Mulette, et al.
Published: (2024-02-01)

Current cough and sputum assessed by the cough and sputum assessment-questionnaire (CASA-Q) is associated with quality of life impairment in cystic fibrosis
by: Lucie Charon, et al.
Published: (2023-11-01)

Early Assessment of Chemotherapy Response in Advanced Non-Small Cell Lung Cancer with Circulating Tumor DNA
by: Stephanie J. Yaung, et al.
Published: (2022-05-01)

Can Liquid Biopsy Based on ctDNA/cfDNA Replace Tissue Biopsy for the Precision Treatment of EGFR-Mutated NSCLC?
by: Yi-Ze Li, et al.
Published: (2023-02-01)

ctDNA Concentration, MIKI67 Mutations and Hyper-Progressive Disease Related Gene Mutations Are Prognostic Markers for Camrelizumab and Apatinib Combined Multiline Treatment in Advanced NSCLC
by: Yao Chen, et al.
Published: (2020-09-01)

Corrigendum: Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis
by: Wei Zhang, et al.
Published: (2022-12-01)

Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis
by: Wei Zhang, et al.
Published: (2022-10-01)

Prevalence and Impact of Rheumatologic Pain in Cystic Fibrosis Adult Patients
by: Axelle Schmoll, et al.
Published: (2022-02-01)

The Value of Liquid Biopsies for Guiding Therapy Decisions in Non-small Cell Lung Cancer
by: Jatta Saarenheimo, et al.
Published: (2019-03-01)

Intratumor heterogeneity comparison among different subtypes of non-small-cell lung cancer through multi-region tissue and matched ctDNA sequencing
by: Yaxiong Zhang, et al.
Published: (2019-01-01)

The Landscape of Actionable Genomic Alterations by Next-Generation Sequencing in Tumor Tissue Versus Circulating Tumor DNA in Chinese Patients With Non-Small Cell Lung Cancer
by: Jun Cai, et al.
Published: (2022-02-01)

Prognostic Factors in Advanced Non-Small Cell Lung Cancer Patients Treated with Immunotherapy
by: Danilo Rocco, et al.
Published: (2023-09-01)

Early Circulating Tumour DNA Variations Predict Tumour Response in Melanoma Patients Treated with Immunotherapy
by: Laura Keller, et al.
Published: (2018-11-01)

Circulating Biomarkers of Response and Toxicity of Immunotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC): A Comprehensive Review
by: Alice Indini, et al.
Published: (2021-04-01)